| Title |
Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, April 2021
|
| DOI | 10.2147/tcrm.s301817 |
| Pubmed ID | |
| Authors |
Sultan A M Saghir, Naif A AlGabri, Mahmoud M Alagawany, Youssef A Attia, Salem R Alyileili, Shaaban S Elnesr, Manal E Shafi, Omar Y A Al-Shargi, Nader Al-Balagi, Abdullah S Alwajeeh, Omar S A Alsalahi, Amlan K Patra, Asmaa F Khafaga, Ahmed Negida, Ahmed Noreldin, Wesam Al-Amarat, Amer A Almaiman, Khaled A El-Tarabily, Mohamed E Abd El-Hack |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 4 | 11% |
| United Kingdom | 4 | 11% |
| Germany | 2 | 5% |
| Brazil | 2 | 5% |
| Dominican Republic | 1 | 3% |
| Indonesia | 1 | 3% |
| Belgium | 1 | 3% |
| United States | 1 | 3% |
| Portugal | 1 | 3% |
| Other | 4 | 11% |
| Unknown | 17 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 84% |
| Scientists | 4 | 11% |
| Practitioners (doctors, other healthcare professionals) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 227 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 227 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 29 | 13% |
| Student > Master | 22 | 10% |
| Researcher | 13 | 6% |
| Student > Ph. D. Student | 11 | 5% |
| Professor > Associate Professor | 7 | 3% |
| Other | 28 | 12% |
| Unknown | 117 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 17 | 7% |
| Biochemistry, Genetics and Molecular Biology | 11 | 5% |
| Nursing and Health Professions | 11 | 5% |
| Immunology and Microbiology | 7 | 3% |
| Other | 29 | 13% |
| Unknown | 119 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2024.
All research outputs
#881,443
of 25,393,528 outputs
Outputs from Therapeutics and Clinical Risk Management
#38
of 1,323 outputs
Outputs of similar age
#25,025
of 453,709 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 19 outputs
Altmetric has tracked 25,393,528 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,709 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.